Amyris, Inc. (NASDAQ:AMRS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company.
Amyris, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.49 in the quarter versus EPS of $-1.15 in the year-earlier quarter.
Revenue: Decreased 85.92% to $5.85 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Amyris, Inc. reported adjusted EPS loss of $-0.49 per share. By that measure, the company missed the mean analyst estimate of $-0.41. It missed the average revenue estimate of $10.68 million.
Quoting Management:“In the final quarter of 2012, we completed commissioning and began commercial production of our industrial-scale farnesene production plant in Brazil. Also, we secured additional capital from some of our largest shareholders,” said John Melo, President & CEO of Amyris. “Amyris is focused on continued execution of our business strategy with the goal of achieving positive cash flow in 2014, underpinned by a reduced operating expense profile, strong product and collaboration revenues, and ongoing support from our investors,” Melo concluded.
Key Stats (on next page)…